{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:22:25Z","timestamp":1788506545829,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vhri.2025.101505","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:56:17Z","timestamp":1759877777000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Valuation of EQ-5D Health States for Adults in Low-, Lower-Middle, and Upper-Middle-Income Countries: A Systematic Review"],"prefix":"10.1016","volume":"51","author":[{"given":"Marufa","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammod A.","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumana","family":"Huque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahangir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0266462317004469","article-title":"Importance of contextual data in producing health technology assessment recommendations: a case study","volume":"34","author":"Poder","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vhri.2025.101505_bib3","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"6","key":"10.1016\/j.vhri.2025.101505_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jval.2013.05.006","article-title":"Health state valuation in low- and middle-income countries: a systematic review of the literature","volume":"16","author":"Kularatna","year":"2013","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00019053-200826040-00003","article-title":"The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4","volume":"26","author":"Scuffham","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.vhri.2025.101505_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.vhri.2025.101505_bib8","author":"EuroQoL"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X13480852","article-title":"Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist","volume":"34","author":"Xie","year":"2014","journal-title":"Med Decis Mak"},{"issue":"5","key":"10.1016\/j.vhri.2025.101505_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1524-4733.2009.00509.x","article-title":"Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries","volume":"12","author":"Bernert","year":"2009","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","article-title":"A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol","volume":"17","author":"Oppe","year":"2014","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.vhri.2025.101505_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","article-title":"EuroQol protocols for time trade-off valuation of health outcomes","volume":"34","author":"Oppe","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","article-title":"Overview, update, and lessons learned from the international EQ-5D-5L valuation work: Version 2 of the EQ-5D-5L Valuation Protocol","volume":"22","author":"Stolk","year":"2019","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.vhri.2025.101505_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1524-4733.2009.00581.x","article-title":"International comparisons in valuing EQ-5D health states: a review and analysis","volume":"12","author":"Norman","year":"2009","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.vhri.2025.101505_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40273-015-0292-9","article-title":"A checklist for reporting valuation studies of multi-attribute utility-based instruments (CREATE)","volume":"33","author":"Xie","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.vhri.2025.101505_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10198-024-01712-z","article-title":"Valuation of the EQ-5D-3L in Jordan","volume":"26","author":"Al Rabayah","year":"2025","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib19","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s11136-023-03378-1","article-title":"A national survey of Iranian general population to estimate a value set for the EQ-5D-5L","volume":"32","author":"Afshari","year":"2023","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.vhri.2025.101505_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40273-021-01101-x","article-title":"Developing the EQ-5D-5L value set for Uganda using the \u2018lite\u2019 protocol","volume":"40","author":"Yang","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.vhri.2025.101505_bib21","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s11136-022-03143-w","article-title":"Estimating the EQ-5D-5L value set for the Philippines","volume":"31","author":"Miguel","year":"2022","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","article-title":"Development of an EQ-5D value set for India using an extended design (DEVINE) study: the Indian 5-level version EQ-5D value set","volume":"25","author":"Jyani","year":"2022","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40273-021-01100-y","article-title":"The EQ-5D-5L valuation study in Egypt","volume":"40","author":"Al Shabasy","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib24","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s11136-021-02804-6","article-title":"Valuation of the EQ-5D-3L in Russia","volume":"30","author":"Omelyanovskiy","year":"2021","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.vhri.2025.101505_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40258-021-00658-0","article-title":"EQ-5D-5L health-state values for the Mexican population","volume":"19","author":"Gutierrez-Delgado","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"10.1016\/j.vhri.2025.101505_bib26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11136-020-02730-z","article-title":"Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L","volume":"30","author":"Chemli","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.vhri.2025.101505_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vhri.2019.08.475","article-title":"Valuing health state: an EQ-5D-5L value set for Ethiopians","volume":"22","author":"Welie","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib28","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s11136-020-02469-7","article-title":"An EQ-5D-5L value set for Vietnam","volume":"29","author":"Mai","year":"2020","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jval.2020.05.004","article-title":"Peruvian valuation of the EQ-5D-5L: A direct comparison of time trade-off and discrete choice experiments","volume":"23","author":"Augustovski","year":"2020","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101505_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40273-018-0758-7","article-title":"EQ-5D-5L valuation for the Malaysian population","volume":"37","author":"Shafie","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2025.101505_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vhri.2019.01.007","article-title":"Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran","volume":"18","author":"Goudarzi","year":"2019","journal-title":"Value Health Reg Issues"},{"issue":"11","key":"10.1016\/j.vhri.2025.101505_bib32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jval.2018.04.1370","article-title":"Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey","volume":"21","author":"Zhuo","year":"2018","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101505_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L Valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.vhri.2025.101505_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-017-0538-9","article-title":"The Indonesian EQ-5D-5L value set","volume":"35","author":"Purba","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L value set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2025.101505_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0272989X15613521","article-title":"Brazilian valuation of EQ-5D-3L health states: results from a saturation study","volume":"36","author":"Santos","year":"2016","journal-title":"Med Decis Mak"},{"issue":"7","key":"10.1016\/j.vhri.2025.101505_bib37","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11136-014-0906-2","article-title":"Valuing EQ-5D health states for Sri Lanka","volume":"24","author":"Kularatna","year":"2015","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.vhri.2025.101505_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jval.2014.05.007","article-title":"Chinese time trade-off values for EQ-5D health states","volume":"17","author":"Liu","year":"2014","journal-title":"Value Health"},{"issue":"1 suppl","key":"10.1016\/j.vhri.2025.101505_bib39","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jval.2011.11.024","article-title":"Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods","volume":"15","author":"Yusof","year":"2012","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1524-4733.2008.00468.x","article-title":"Argentine valuation of the EQ-5D health states","volume":"12","author":"Augustovski","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-1-11","article-title":"How do Zimbabweans value health states?","volume":"1","author":"Jelsma","year":"2003","journal-title":"Popul Health Metr"},{"issue":"2","key":"10.1016\/j.vhri.2025.101505_bib42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0272989X15601047","article-title":"Logical inconsistencies in 3 preference elicitation methods for EQ-5D health states: a study in the Brazilian population","volume":"36","author":"Andrade","year":"2016","journal-title":"Med Decis Mak"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11136-019-02292-9","article-title":"Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China","volume":"29","author":"Hao","year":"2020","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11136-015-1129-x","article-title":"Is bad living better than good death? Impact of demographic and cultural factors on health state preference","volume":"25","author":"Jin","year":"2016","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.vhri.2025.101505_bib45","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11136-023-03394-1","article-title":"Urban\/rural differences in preferences for EQ-5D-5L health states: a study of a multi-ethnic region in China","volume":"32","author":"Liao","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12955-022-01917-x","article-title":"Rural population\u2019s preferences matter: a value set for the EQ-5D-3L health states for China\u2019s rural population","volume":"20","author":"Liu","year":"2022","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.vhri.2025.101505_bib47","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jval.2011.06.005","article-title":"Estimating population-based values for EQ-5D health states in Thailand","volume":"14","author":"Tongsiri","year":"2011","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.vhri.2025.101505_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vhri.2013.01.009","article-title":"Societal preferences for EQ-5D health states from a Brazilian population survey","volume":"2","author":"Viegas Andrade","year":"2013","journal-title":"Value Health Reg Issues"},{"issue":"8","key":"10.1016\/j.vhri.2025.101505_bib49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10198-014-0635-z","article-title":"Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese","volume":"16","author":"Wang","year":"2015","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.vhri.2025.101505_bib50","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.21584","article-title":"Population-based preference weights for the EQ-5D health states using the visual analogue scale (VAS) in Iran","volume":"18","author":"Goudarzi","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.vhri.2025.101505_bib51","article-title":"An EQ-5D-5L value set for Ghana using an adapted EuroQol valuation technology protocol","volume":"45","author":"Addo","year":"2024","journal-title":"Value Health Reg Issues"},{"issue":"6","key":"10.1016\/j.vhri.2025.101505_bib52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s41669-023-00437-8","article-title":"The EQ-5D-3L valuation study in Pakistan","volume":"7","author":"Malik","year":"2023","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.vhri.2025.101505_bib53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vhri.2022.04.006","article-title":"Incorporating concern for health equity into resource allocation decisions: development of a tool and population-based valuation for Uganda","volume":"31","author":"Yang","year":"2022","journal-title":"Value Health Reg Issues"},{"issue":"suppl 2","key":"10.1016\/j.vhri.2025.101505_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40273-022-01226-7","article-title":"EQ-5D-Y-3L value sets, valuation methods and conceptual questions","volume":"40","author":"Devlin","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.vhri.2025.101505_bib55","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jval.2019.06.008","article-title":"Toward a smaller design for EQ-5D-5L valuation studies","volume":"22","author":"Yang","year":"2019","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101505_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hec.673","article-title":"Estimating an EQ-5D population value set: the case of Japan","volume":"11","author":"Tsuchiya","year":"2022","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.vhri.2025.101505_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jval.2011.04.009","article-title":"Time trade-off derived EQ-5D weights for Australia","volume":"14","author":"Viney","year":"2011","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.vhri.2025.101505_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051727","article-title":"EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study","volume":"11","author":"Al Shabasy","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vhri.2025.101505_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13104-019-4067-9","article-title":"Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results","volume":"12","author":"Gerlinger","year":"2019","journal-title":"BMC Res Notes"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925004315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:24:21Z","timestamp":1773159861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925004315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S2212109925004315"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101505","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valuation of EQ-5D Health States for Adults in Low-, Lower-Middle, and Upper-Middle-Income Countries: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101505"}}